13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 2 managers

Reported value

$4.23M

Holders

2

+0 new · −0 exited

Holders’ est. mark

$1.91M

Price effect on 2 books still in the name

Largest holder

$3.78M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC255.4K$3.78M$1.71MCut−$3.01M
Leonteq Securities AG30.2K$447.6K$202KAdded$41.1K

Positions as of Q1 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.